MENU
DNLI
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Denali Therapeutics (DNLI) Earnings Date & Reports

Industry: @Biotechnology
A.I. Advisor
published Earnings

DNLI is expected to report earnings to rise 32.08% to -83 cents per share on March 03

Denali Therapeutics DNLI Stock Earnings Reports
Q4'24
Est.
$-0.83
Q3'24
Missed
by $0.03
Q2'24
Beat
by $0.08
Q1'24
Beat
by $0.02
Q4'23
Missed
by $0.06
The last earnings report on November 06 showed earnings per share of -62 cents, missing the estimate of -59 cents. With 28.61K shares outstanding, the current market capitalization sits at 3.34B.
View a ticker or compare two or three
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a biotechnology company

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
161 Oyster Point Boulevard
Phone
+1 650 866-8548
Employees
445
Web
https://www.denalitherapeutics.com